BEKADJA, M. A. OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 9, n. 1, p. e2017062, 2017. DOI: 10.4084/mjhid.2017.062. Disponível em: https://www.mjhid.org/index.php/mjhid/article/view/2017.062. Acesso em: 13 jun. 2021.